Hamilton Thorne Ltd. (CVE:HTL – Get Free Report) crossed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of C$1.45 and traded as low as C$1.42. Hamilton Thorne shares last traded at C$1.45, with a volume of 25,700 shares.
Hamilton Thorne Stock Up 4.3%
The stock has a market capitalization of C$149.69 million, a price-to-earnings ratio of 58.94 and a beta of 0.54. The business has a 50-day moving average of C$1.45 and a 200-day moving average of C$1.45. The company has a debt-to-equity ratio of 43.24, a quick ratio of 2.25 and a current ratio of 2.04.
Hamilton Thorne Company Profile
Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. It offers precision laser systems, imaging systems, and other equipment and consumables for the ART and developmental biology research markets. The company also provides test laboratory and endotoxin testing services, as well as sperm assays, including Sperm Motility Index and Sperm Penetration; and fresh and cryopreserved mouse embryos supply, and technician training and proficiency testing services.
Featured Articles
- Five stocks we like better than Hamilton Thorne
- Aehr Spikes on New Order, But Has Stock Gotten Ahead of Itself?
- Rackspace’s AI Land Grab: Plugging Into the Next Compute Boom
- Satellogic Is Tiny But Its Revenue Growth Is Hard to Ignore
- Why Kroger’s Pullback Could Be a Gift for Patient Investors
Receive News & Ratings for Hamilton Thorne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hamilton Thorne and related companies with MarketBeat.com's FREE daily email newsletter.
